DK191A - LEADER SEQUENCE CREATING A POST-TRANSLATIONAL MODIFICATION OF POLYPEPTIDES IN BACTERIES, AND THEREFORE - Google Patents

LEADER SEQUENCE CREATING A POST-TRANSLATIONAL MODIFICATION OF POLYPEPTIDES IN BACTERIES, AND THEREFORE Download PDF

Info

Publication number
DK191A
DK191A DK000191A DK191A DK191A DK 191 A DK191 A DK 191A DK 000191 A DK000191 A DK 000191A DK 191 A DK191 A DK 191A DK 191 A DK191 A DK 191A
Authority
DK
Denmark
Prior art keywords
polypeptides
post
leader sequence
bacteries
translational modification
Prior art date
Application number
DK000191A
Other languages
Danish (da)
Other versions
DK191D0 (en
Inventor
Norman J Hansen
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of DK191A publication Critical patent/DK191A/en
Publication of DK191D0 publication Critical patent/DK191D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The method by which polypeptides having residues other than the 20 common amino acids are made is established. A leader peptide sequence, and its gene, are identified which induce or assist post-translational modifications of Cys, Thr and Ser in prokaryotes. The leader sequence may be used to induce the presence of covalent bonding sites in polypeptides and can be expressed by either naturally occurring or artificial means.
DK000191A 1988-07-05 1991-01-02 LEADER SEQUENCE CREATING A POST-TRANSLATIONAL MODIFICATION OF POLYPEPTIDES IN BACTERIES, AND THEREFORE DK191D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/214,959 US5218101A (en) 1988-07-05 1988-07-05 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
PCT/US1989/002820 WO1990000558A1 (en) 1988-07-05 1989-06-30 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor

Publications (2)

Publication Number Publication Date
DK191A true DK191A (en) 1991-01-02
DK191D0 DK191D0 (en) 1991-01-02

Family

ID=22801074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK000191A DK191D0 (en) 1988-07-05 1991-01-02 LEADER SEQUENCE CREATING A POST-TRANSLATIONAL MODIFICATION OF POLYPEPTIDES IN BACTERIES, AND THEREFORE

Country Status (14)

Country Link
US (1) US5218101A (en)
EP (1) EP0423224B1 (en)
JP (2) JP3326172B2 (en)
KR (1) KR0137961B1 (en)
AT (1) ATE175417T1 (en)
AU (1) AU640110B2 (en)
CA (1) CA1339414C (en)
DE (2) DE68928899T4 (en)
DK (1) DK191D0 (en)
IL (1) IL90832A (en)
NO (1) NO309200B1 (en)
NZ (1) NZ229538A (en)
WO (1) WO1990000558A1 (en)
ZA (1) ZA894721B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
US5348881A (en) * 1990-03-13 1994-09-20 Quest International Flavors & Good Ingredients Company, Division Of Indopco, Inc. Multiple bacteriocin producing lactococcus and compositions
NL9000753A (en) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst DNA FRAGMENT, AT LEAST CODING FOR PART OF THE EXTRACELLULAR PROTEIN WITH AN APPARENT 60 KDA MOLECULAR WEIGHT OF LACTOCOCCUS LACTIS STAMPS LIKE LACTOCOCCUS LACTIS SSP. LACTIS TRIBE MG1363, COMBINATIONS WITH HOMOLOGUE OR HETEROLOGOUS PROTEINS CODING DNA SEQUENCES AND HOMOLOGOUS AND HEREOLY PROTEINS OBTAINED.
EP0579730B1 (en) * 1991-04-11 2003-02-26 Stichting Nederlands Instituut Voor Zuivelonderzoek (Nizo) Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics
US5861376A (en) * 1991-07-01 1999-01-19 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Synthetically derived peptide
GB9207267D0 (en) * 1992-04-02 1992-05-13 Agricultural & Food Res Nisins
EP0700998B1 (en) * 1994-09-12 2003-11-26 Aventis Pharma Deutschland GmbH Recombinant mersacidin and a method for production
US5919695A (en) * 1997-04-22 1999-07-06 Quest International, B.V. Method and culture for inhibiting undesired microorganisms with culture of Bacillus subtilis
US6953683B2 (en) * 1997-07-18 2005-10-11 University Of Maryland Compositions and methods of inhibiting bacterial spore germination
AU8484798A (en) 1997-07-18 1999-02-10 University Of Maryland Sublancin lantibiotic produced by (bacillus subtilis) 168
CA2356955A1 (en) * 1998-12-24 2000-07-06 University Of Maryland Stable subtilin and methods of manufacture
US6759205B2 (en) 2000-06-29 2004-07-06 University Of Maryland Construction of a strain of Bacillus subtilis 168 that displays the sublancin lantibiotic on the surface of the cell
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
US7033766B2 (en) * 2000-06-29 2006-04-25 University Of Maryland Office Of Technology Commercialization Construction and screening of lantibody display libraries
WO2003063887A1 (en) * 2002-01-14 2003-08-07 University Of Maryland, College Park Compositions and method of inhibiting bacterial spore germination
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
DE602005009738D1 (en) 2004-12-07 2008-10-23 Applied Nanosystems Bv METHOD FOR THE PRODUCTION AND SECRETION OF MODIFIED PEPTIDES
CA2641763A1 (en) * 2006-02-13 2007-08-23 Boehringer Ingelheim Vetmedica Gmbh Method for the manufacture of lantibiotics
US7910695B2 (en) * 2006-06-29 2011-03-22 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7993873B2 (en) * 2006-06-29 2011-08-09 The Invention Science Fund I, Llc Apparatus for arbitrary peptide synthesis
US7923533B2 (en) * 2006-06-29 2011-04-12 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis
US7879975B2 (en) * 2006-06-29 2011-02-01 The Invention Science Fund I, Llc Methods for arbitrary peptide synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716115A (en) * 1983-09-06 1987-12-29 Microlife Technics, Inc. Derived nisin producing microorganisms, method of production and use and products obtained thereby

Also Published As

Publication number Publication date
JPH03505670A (en) 1991-12-12
EP0423224B1 (en) 1999-01-07
IL90832A (en) 1995-06-29
JP3326172B2 (en) 2002-09-17
US5218101A (en) 1993-06-08
ATE175417T1 (en) 1999-01-15
AU640110B2 (en) 1993-08-19
KR900701819A (en) 1990-12-04
IL90832A0 (en) 1990-01-18
ZA894721B (en) 1990-03-28
JP3418388B2 (en) 2003-06-23
EP0423224A1 (en) 1991-04-24
NO905638D0 (en) 1990-12-28
KR0137961B1 (en) 1998-04-30
DE68928899T4 (en) 1999-11-25
DE68928899T2 (en) 1999-08-12
AU3968489A (en) 1990-02-05
NO905638L (en) 1990-12-28
WO1990000558A1 (en) 1990-01-25
JP2002191383A (en) 2002-07-09
EP0423224A4 (en) 1991-11-06
NZ229538A (en) 1992-01-29
DE68928899D1 (en) 1999-02-18
CA1339414C (en) 1997-09-02
DK191D0 (en) 1991-01-02
NO309200B1 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
DK191D0 (en) LEADER SEQUENCE CREATING A POST-TRANSLATIONAL MODIFICATION OF POLYPEPTIDES IN BACTERIES, AND THEREFORE
DE68927088D1 (en) Human vascular permeability factor
DK1019073T3 (en) Apoliprotein A-I agonists and their use in treating dyslipidemic disorders
DK0643767T3 (en) Osteogenic peptides
NL300062I2 (en) Osteogenic agents.
ATE138102T1 (en) METHOD FOR PRODUCING CYSTEIN-FREE PEPTIDES
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
DK0532587T3 (en) Methods for trans-destabilizing specific proteins in vivo
DK156592D0 (en) HUMAN-H1-PREEPRORELAXIN, -PRORELAXIN AND -RELAXIN, AND POLYPEPTIDE WITH RELAXIN ACTIVITY AND PROCEDURE FOR COMPOUNDING THE A AND B CHAINS IN HUMAN-H1-RELAXIN
ES548617A0 (en) PROCEDURE TO DISCOUNT PEPTIDES AND PROTEINS IN THE ENLA-CE METIONILO
BR9809416A (en) Process for cleavage of fusion proteins
DK627687D0 (en) hirudin
FI885296A7 (en) Recombinant HIV-2 polypeptide
DE3873273D1 (en) METHOD FOR SELECTIVE CLEAVAGE OF FUSION PROTEINS.
ES2078229T3 (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE SIMILAR TO MOTILINE AND ITS EXPRESSION.
DK196689A (en) EXPRESSION OF THE PRAES2 PROTEIN FOR HEPATITIS B IN METHYLOTROPHIC GAERTS
NO881502D0 (en) RECOMBINANT HTLV-111 PROTEINS AND THE USE OF THESE.
ES2056872T3 (en) ANTICOAGULANT PROTEIN PP4-X, ITS PREPARATION AND USE.
ATE110775T1 (en) PROCESS FOR PRODUCTION OF HIRUDIN.
DK0540560T3 (en) Ancrod-like proteins, their preparation and use
ATE416781T1 (en) ANTIGENIC MODIFICATION OF POLYPEPTIDES
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
ATE91303T1 (en) PROCESS FOR THE PRODUCTION OF PEPTIDES BY SPECIFIC CLEAVAGE OF GENETICALLY DERIVED FUSION PROTEINS WITH COLLAGENASES.
ATE76081T1 (en) PROCESS FOR THE PREPARATION OF DIPEPTIDS WITH N-TERMINAL NON-PROTEINOGENIC AMINO ACIDS.
ATE128717T1 (en) SCHIZOSACCHAROMYCES-SPECIFIC POLYPEPTIDES.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment